Substance Use Disorders

An analysis of recent drug use in the United States revealed unexpected trends in substances being used in tandem with fentanyl, according to an expert.

Individuals who required hospital-based care for cannabis use disorder faced nearly three times the risk for premature death, results from a cohort analysis published in JAMA Network Open showed.

Less than 7% of individuals with mental health or substance use disorders receive effective treatment worldwide, according to a cross-sectional analysis published in JAMA Psychiatry.

As the body of research expands on the potential of glucagon-like peptide-1 receptor agonists to address various health issues, recent data suggest they may improve brain health.

An online-based mindfulness treatment program significantly reduced opioid craving among participants with opioid use disorder results from a randomized clinical trial published in JAMA Network Open showed.

The volume of those who received medications for opioid use disorder at federally qualified health centers more than doubled over a recent 6-year span, results from a cross-sectional study showed.

Glucagon-like peptide-1 receptor agonist use corresponded with risk reductions for dozens of diseases and adverse health outcomes, such as dementia and stroke, a new analysis published in Nature Medicine showed.

Women who used the Continuous Precision Medicine mobile application had a lower likelihood of misusing prescription opioids after cesarean section vs. nonusers, researchers reported in BMC Pregnancy and Childbirth.

Inhaling fumes from household objects, or “chroming,” has become increasingly popular among minors on social media platforms like TikTok, according to our most popular adolescent medicine story in 2024.

Less than 10% of reproductive aged women with opioid use disorder and hepatitis C virus are treated for HCV, according to findings published in Clinical Infectious Diseases.